Primary Job Title Founder Primary Organization 
Eton Pharmaceuticals
Location Greater San Diego Area, California, United States Regions West Coast, Western US Gender Male
Website www.marklbaum.com LinkedIn View on LinkedIn
Mark L. Baum is the founder of and serves as the CEO of Harrow Health, Inc. (NASDAQ: HROW). For the 2014-2017 periods, Harrow (formerly Imprimis Pharmaceuticals) was named by Deloitte’s Technology Fast 500™ as one of the fastest growing companies in North America. Mr. Baum is also a founder of Eton Pharmaceuticals (NASDAQ: ETON), as well as a
founder and board member of Surface Ophthalmics, Melt Pharmaceuticals, and Visionology.com. From 2014-2017, Mr. Baum was a senior advisor to Curology.com, a leading tele-dermatology platform. Prior to Harrow, as the founder of TBLF, LLC, a private investment fund manager, Mr. Baum made more than 200 investments into more than 40 private and public companies. In 1999, Mr. Baum founded YesRx, an HIV-focused pharmacy business. Mr. Baum’s advocacy for drug pricing and patient and physician prescription medication accessibility issues has been featured in Op-Ed contributions for the Wall Street Journal and through appearances on numerous national media outlets. Mr. Baum was named by Ernst & Young LLP as the 2017 Entrepreneur of the Year™ in the life sciences category for the San Diego region. Mr. Baum is a graduate, cum laude, of The University of Texas at Arlington and a 1997 graduate of California Western School of Law.
